Journey Medical Corp
NASDAQ:DERM

Watchlist Manager
Journey Medical Corp Logo
Journey Medical Corp
NASDAQ:DERM
Watchlist
Price: 5.37 USD 3.27% Market Closed
Market Cap: 107.4m USD
Have any thoughts about
Journey Medical Corp?
Write Note

Wall Street
Price Targets

DERM Price Targets Summary
Journey Medical Corp

Wall Street analysts forecast DERM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DERM is 10.2 USD with a low forecast of 9.09 USD and a high forecast of 11.55 USD.

Lowest
Price Target
9.09 USD
69% Upside
Average
Price Target
10.2 USD
90% Upside
Highest
Price Target
11.55 USD
115% Upside
Journey Medical Corp Competitors:
Price Targets
NKTR
Nektar Therapeutics
298% Upside
053030
Binex Co Ltd
122% Upside
JUBLPHARMA
Jubilant Pharmova Ltd
19% Upside
FULC
Fulcrum Therapeutics Inc
66% Upside
TARS
Tarsus Pharmaceuticals Inc
37% Upside
170900
Dong-A ST Co Ltd
46% Upside
086450
Dongkook Pharmaceutical Co Ltd
49% Upside
CORT
Corcept Therapeutics Inc
33% Upside

Revenue
Forecast

Revenue Estimate
Journey Medical Corp

For the last 3 years the compound annual growth rate for Journey Medical Corp's revenue is 21%. The projected CAGR for the next 3 years is 1%.

21%
Past Growth
1%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Journey Medical Corp

For the last 3 years the compound annual growth rate for Journey Medical Corp's operating income is -49%.

-49%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Journey Medical Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DERM's stock price target?
Price Target
10.2 USD

According to Wall Street analysts, the average 1-year price target for DERM is 10.2 USD with a low forecast of 9.09 USD and a high forecast of 11.55 USD.

What is Journey Medical Corp's Revenue forecast?
Projected CAGR
1%

For the last 3 years the compound annual growth rate for Journey Medical Corp's revenue is 21%. The projected CAGR for the next 3 years is 1%.

Back to Top